Financial statements Dolbiotech
Balance sheet data of DOLBIOTECH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 20 435,47 | 67 091,58 | 106 790,78 | 834 659,36 | 1 467 626,68 | 1 420 736,46 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 162 453,49 | 133 619,22 | 100 075,45 |
| B. Current assets | 20 435,47 | 67 091,58 | 106 790,78 | 672 205,87 | 1 334 007,46 | 1 320 661,01 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 20 435,47 | 67 091,58 | 106 790,78 | 834 659,36 | 1 467 626,68 | 1 420 736,46 |
| A. Equity | -33 043,95 | -31 945,67 | 59 641,13 | 224 979,78 | 442 317,23 | 867 389,09 |
| B. Liabilities and provisions for liabilities | 53 479,42 | 99 037,25 | 47 149,65 | 609 679,58 | 1 025 309,45 | 553 347,37 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 345 645,18 | 66 769,17 | 30 986,61 |
| II. Short-term liabilities | 53 479,42 | 99 037,25 | 47 149,65 | 264 034,40 | 958 540,28 | 522 360,76 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.